✦ LIBER ✦

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry

✍ Scribed by Atzeni, Fabiola; Sarzi-Puttini, Piercarlo; Botsios, Costantino; Carletto, Antonio; Cipriani, Paola; Favalli, Ennio Giulio; Frati, Elena; Foschi, Valentina; Gasparini, Stefania; Giardina, AnnaRita; Gremese, Elisa; Iannone, Florenzo; Sebastiani, Marco; Ziglioli, Tamara; Biasi, Domenico; Ferri, Clodoveo; Galeazzi, Mauro; Gerli, Roberto; Giacomelli, Roberto; Gorla, Roberto; Govoni, Marcello; Lapadula, Giovanni; Marchesoni, Antonio; Salaffi, Fausto; Punzi, Leonardo; Triolo, Giovanni; Ferraccioli, Gianfranco

Book ID: 118426167
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 180 KB
Volume: 12
Category: Article
ISSN: 1568-9972
DOI: 10.1016/j.autrev.2012.06.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors for the 5-year risk of seriou

Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

✍ van Dartel, S. A. A.; Fransen, J.; Kievit, W.; Dutmer, E. A. J.; Brus, H. L. M.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 104 KB

Anti–tumor necrosis factor α therapy and

Anti–tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis

✍ Sebastian Schneeweiss; Soko Setoguchi; Michael E. Weinblatt; Jeffrey N. Katz; Je 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif

A comparative effectiveness study of ada

A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry

✍ Greenberg, J. D.; Reed, G.; Decktor, D.; Harrold, L.; Furst, D.; Gibofsky, A.; D 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 200 KB

PMS2 Risk and Cost of Infections in Rheu

PMS2 Risk and Cost of Infections in Rheumatoid Arthritis Patients Treated with anti-TNF therapy in Alberta, Canada

✍ A. Ohinmaa; N.X. Thanh; J. Homik; C. Barnabe; L. Martin; S. Barr; W. Maksymowych 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

The risk of serious infection in patient

The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database

✍ Sakai, Ryoko; Cho, Soo-Kyung; Nanki, Toshihiro; Koike, Ryuji; Watanabe, Kaori; Y 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 250 KB

Does Anti-Tumor Necrosis Factor- Therapy

Does Anti-Tumor Necrosis Factor- Therapy Affect Risk of Serious Infection and Cancer in Patients with Rheumatoid Arthritis?: A Review of Longterm Data

✍ KEYSTONE, E. C. 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 355 KB